• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡瓦胡椒治疗焦虑症状的疗效和安全性:系统评价和随机临床试验分析。

The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials.

机构信息

Allied Health Sciences, Grand Valley State University, 515 Michigan St NE - Suite 200, Grand Rapids, MI, 49503, USA; College of Health Professions, Central Michigan University, Health Professions Building 1222, Mount Pleasant, MI, 48859, USA.

Allied Health Sciences, Grand Valley State University, 515 Michigan St NE - Suite 200, Grand Rapids, MI, 49503, USA.

出版信息

Complement Ther Clin Pract. 2018 Nov;33:107-117. doi: 10.1016/j.ctcp.2018.09.003. Epub 2018 Sep 15.

DOI:10.1016/j.ctcp.2018.09.003
PMID:30396607
Abstract

BACKGROUND

To determine if Kava Kava is an effective treatment for combating symptoms of anxiety despite warnings of hepatotoxicity from the Centers for Disease Control and Prevention (CDC).

METHODS

Databases PubMed, CINAHL, and PsycINFO were utilized to obtain clinical trials on Kava Kava and its effects on anxiety. A total of 11 articles met inclusion/exclusion criteria: 2 for Kava Kava vs. another anti-anxiety medication, 2 detailing additional adverse events, and 7 for Kava Kava vs. placebo. Mantel-Haenszel fixed-effects model was used to analyze the data, with responder rates being pooled to compute weighted risk ratios.

RESULTS

Kava Kava was shown to be more effective than placebo in 3 of the 7 trials. A final risk ratio of 1.50 (95% CI: 1.12, 2.01) from responder rates was calculated in favor of the intervention from 5 clinical trials (n = 330). Adverse events were shown to be the same as placebo (P = 0.574), and laboratory values analyzing hepatotoxicity were no different when compared to baseline except in two studies.

CONCLUSIONS

Kava Kava appears to be a short-term treatment for anxiety, but not a replacement for prolonged anti-anxiety use. Although not witnessed in this review, liver toxicity is especially possible if taken longer than 8 weeks.

摘要

背景

尽管疾病预防控制中心 (CDC) 警告称卡瓦具有肝毒性,但仍要确定卡瓦是否能有效治疗焦虑症状。

方法

利用 PubMed、CINAHL 和 PsycINFO 数据库获取关于卡瓦及其对焦虑影响的临床试验。共有 11 篇文章符合纳入/排除标准:2 篇为卡瓦与另一种抗焦虑药物的比较,2 篇详细介绍了其他不良事件,7 篇为卡瓦与安慰剂的比较。采用 Mantel-Haenszel 固定效应模型分析数据,汇总应答率以计算加权风险比。

结果

在 7 项试验中的 3 项中,卡瓦比安慰剂更有效。来自 5 项临床试验(n=330)的应答率最终计算出的干预风险比为 1.50(95%CI:1.12, 2.01)。不良事件与安慰剂相同(P=0.574),与基线相比,除了两项研究外,分析肝毒性的实验室值没有差异。

结论

卡瓦似乎是一种短期治疗焦虑的方法,但不能替代长期使用抗焦虑药物。虽然在本综述中未观察到,但如果服用时间超过 8 周,肝毒性尤其可能发生。

相似文献

1
The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials.卡瓦胡椒治疗焦虑症状的疗效和安全性:系统评价和随机临床试验分析。
Complement Ther Clin Pract. 2018 Nov;33:107-117. doi: 10.1016/j.ctcp.2018.09.003. Epub 2018 Sep 15.
2
Kava extract for treating anxiety.用于治疗焦虑症的卡瓦提取物。
Cochrane Database Syst Rev. 2003;2003(1):CD003383. doi: 10.1002/14651858.CD003383.
3
Kava extract for treating anxiety.用于治疗焦虑症的卡瓦提取物。
Cochrane Database Syst Rev. 2002(2):CD003383. doi: 10.1002/14651858.CD003383.
4
Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.卡瓦提取物治疗焦虑症的疗效:系统评价与荟萃分析。
J Clin Psychopharmacol. 2000 Feb;20(1):84-9. doi: 10.1097/00004714-200002000-00014.
5
Kava extract for treating anxiety.用于治疗焦虑症的卡瓦提取物。
Cochrane Database Syst Rev. 2001(4):CD003383. doi: 10.1002/14651858.CD003383.
6
A systematic review of the safety of kava extract in the treatment of anxiety.卡瓦提取物治疗焦虑症安全性的系统评价。
Drug Saf. 2002;25(4):251-61. doi: 10.2165/00002018-200225040-00003.
7
An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia.一项基于网络的关于卡瓦根和缬草治疗焦虑和失眠的随机、安慰剂对照试验。
Medicine (Baltimore). 2005 Jul;84(4):197-207. doi: 10.1097/01.md.0000172299.72364.95.
8
The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.卡瓦焦虑抑郁谱系研究(KADSS):一项使用卡瓦胡椒水提取物的随机、安慰剂对照交叉试验。
Psychopharmacology (Berl). 2009 Aug;205(3):399-407. doi: 10.1007/s00213-009-1549-9. Epub 2009 May 9.
9
Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.焦虑和焦虑相关障碍的营养和草本补充剂:系统评价。
Nutr J. 2010 Oct 7;9:42. doi: 10.1186/1475-2891-9-42.
10
Kava treatment in patients with anxiety.焦虑症患者的卡瓦治疗
Phytother Res. 2004 Apr;18(4):297-300. doi: 10.1002/ptr.1422.

引用本文的文献

1
Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations.卡瓦的全球视角:关于健康影响、经济和社会影响及政策考量的叙述性系统综述
Drug Alcohol Rev. 2025 Sep;44(6):1601-1640. doi: 10.1111/dar.14080. Epub 2025 Jun 25.
2
Kavalactones support motivation to move during intensive training in males preparing for military special operations forces.卡瓦内酯可支持备战军事特种部队的男性在强化训练期间保持运动积极性。
J Int Soc Sports Nutr. 2024 Dec;21(1):2377194. doi: 10.1080/15502783.2024.2377194. Epub 2024 Jul 15.
3
Development of Certified Reference Material Solutions for Phytochemicals in Ginger and Kava.
姜黄和卡瓦中植物化学物质有证标准物质解决方案的开发。
J AOAC Int. 2024 Jul 4;107(4):663-678. doi: 10.1093/jaoacint/qsae025.
4
An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava.卡瓦的精神活性、毒性及抗癌特性的最新综述
J Clin Med. 2022 Jul 12;11(14):4039. doi: 10.3390/jcm11144039.
5
biosynthesis of diverse plant-derived styrylpyrones in .. 中多种植物源苯乙烯基吡喃酮的生物合成
Metab Eng Commun. 2022 Mar 5;14:e00195. doi: 10.1016/j.mec.2022.e00195. eCollection 2022 Jun.
6
Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava ().卡瓦(Kava)中两种主要生物活性成分——卡瓦内酯和黄酮卡瓦素的生物活性、肝毒性及构效关系
Evid Based Complement Alternat Med. 2021 Aug 20;2021:6851798. doi: 10.1155/2021/6851798. eCollection 2021.
7
Herb-drug Interactions in Neuropsychiatric Pharmacotherapy - A Review of Clinically Relevant Findings.中药-药物相互作用在神经精神药理学治疗中的临床相关研究进展。
Curr Neuropharmacol. 2022 Aug 3;20(9):1736-1751. doi: 10.2174/1570159X19666210809100357.
8
Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1.卡瓦根提取物通过双重抑制单胺氧化酶A(MAO-A)和赖氨酸特异性去甲基化酶1(LSD1)来阻碍前列腺癌的发展和肿瘤发生。
J Transl Genet Genom. 2021;5:163-172. doi: 10.20517/jtgg.2021.22. Epub 2021 May 28.
9
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.焦虑症的药物治疗:当前及新出现的治疗选择
Front Psychiatry. 2020 Dec 23;11:595584. doi: 10.3389/fpsyt.2020.595584. eCollection 2020.
10
A New Hypothesis on Anxiety, Sleep Insufficiency, and Viral Infections; Reciprocal Links to Consider in Today's "World vs. COVID-19" Endeavors.关于焦虑、睡眠不足和病毒感染的新假说;在当今“世界与新冠疫情”的斗争中需考虑的相互联系。
Front Psychiatry. 2020 Nov 5;11:585893. doi: 10.3389/fpsyt.2020.585893. eCollection 2020.